08.25.26 By Kathy Kelleher
Life sciences and health tech organizations have built strong foundations, capable teams, and established processes with years of technology investment. The challenge many are navigating now is getting more value from what they have built.
Data exists, but it is fragmented across systems that were never designed to talk to each other. Platforms have been modernized in parts, but rarely in a sequence that connects technical progress to measurable business outcomes. Meanwhile, the external environment keeps raising the stakes, from interoperability mandates to value-based contracts to IRA pricing pressure. AI-enabled health tech startups captured 62% of all digital health venture funding in the first half of 2025, a signal that well-capitalized competitors are moving quickly, and that the gap between organizations that are functioning and those that are winning is widening.
The organizations pulling ahead are closing that gap with discipline rather than volume: fewer initiatives, each one tied to a specific commercial outcome, each result earning the case for the next investment. What follows covers three areas where that discipline is showing up: turning existing data into a competitive advantage, making smarter decisions about which investments to prioritize, and identifying where to focus first.
Most life sciences organizations already have the data to inform and reshape commercial decisions and daily operations, from member records and claims data to clinical trial outputs, HCP (healthcare provider) engagement signals, patient activation patterns, and even plan documents and workflows employees rely on every day. The challenge is connecting and activating that information in ways that improve decision-making.
A unified approach to data is a critical enabler of growth, efficiency, and commercial performance. Here is how three organizations put that into practice:
A global biopharmaceutical organization was managing DTC campaign analytics across outsourced vendors with limited visibility into what was actually driving brand performance. Bridgenext helped bring measurement and activation in-house, building a compliant clean-room and CDP architecture that gave brand teams direct control over media decisions and closed-loop performance data across Specialty Care, General Medicines, and Vaccines.
Value Gained: privacy-safe audience targeting, unified cross-brand measurement, a governance framework built to HIPAA, GDPR, and MLR standards from day one, reduced agency dependency, and faster campaign activation. Read the full story →
A leading biotechnology trade association had built a robust membership base and active communications programs but lacked a clear picture of what was driving member retention. Bridgenext conducted a data assessment of historical engagement and found that members who served on multiple committees were significantly less likely to churn, immediately shaping the organization’s investment priorities. The organization operationalized that insight through a new committee engagement toolkit, shifting from reactive outreach to proactive, data-backed retention strategies.
Value Gained: Reduced member churn through proactive, personalized engagement strategies; multimillion-dollar cost savings identified by eliminating underperforming communications spend; and a unified data platform via Databricks giving leadership a reliable single source of truth, with board-level ROI demonstrated through early data wins, no lengthy implementation cycle required. Read the full story →
A leading healthcare technology company was managing large volumes of complex medical plan documents that were difficult to navigate, inconsistent in terminology across payers, and largely dependent on manual searches to answer employee questions. Bridgenext built an AI-powered query platform that made those complex plan documents searchable using natural language, integrating governance, security, and human-in-the-loop validation controls to ensure accuracy and compliance at scale.
Value Gained: Faster access to critical plan information, reduced reliance on manual document lookups, improved accuracy through AI and human validation workflows, and greater operational efficiency across large volumes of healthcare documentation. Read the full story →
With a strong data foundation in place, the next challenge is deciding where to invest next. Most life sciences organizations have no shortage of modernization opportunities. Common priorities include:
The difficulty isn’t identifying opportunities; it’s determining which will deliver measurable business value first. The organizations realizing the strongest returns sequence investments based on expected impact, whether that is revenue growth, member retention, operational efficiency, or risk reduction. Each success builds momentum, and with it, the support and funding for the next initiative.
A useful question for leadership teams is: Which investment is most likely to produce a measurable result within the next 12 to 18 months?
Research shows that many healthcare AI initiatives fall short because organizations launch too many programs simultaneously without defining the business outcome each one is expected to improve. Leading organizations take the opposite approach. They start with a high-value business problem, prove impact, and use those results to guide future investments.
The advocacy organization from use case 2 is a good example. Rather than launching a broad technology overhaul, it started with the committee-participation tracking tool tied directly to member retention, its most important strategic metric. Once that value was proven, leadership had the evidence needed to fund additional initiatives confidently.
Organizations undergoing similar CRM modernization efforts across pharma have applied the same discipline, prioritizing the engagement workflows most closely tied to prescriber behavior before expanding investment elsewhere.
Key Takeaway: The best modernization roadmaps aren’t built around technologies. They’re built around business outcomes. Start with the initiative most likely to move a strategic metric, prove value, and use that success to fund what comes next.
The most effective modernization initiatives start with a business outcome. The key question is: Which data or technology gap, if addressed, would have the greatest impact on a strategic objective?
For a pharma brand, that might mean improving visibility into DTC campaign performance. For a health tech company, it could mean using AI to streamline information access and reduce support costs. For a life sciences association, it might be identifying engagement signals that help predict and prevent member churn.
At Bridgenext, we help life sciences and health tech organizations identify the investments most likely to generate measurable returns, align initiatives to business outcomes, and build the capabilities needed to support future growth.
If you’re exploring what’s next, and you’d like a sounding board as you evaluate your options, we’d love to connect. Let’s talk.
Identify the commercial outcome that matters most, revenue, retention, efficiency, or risk reduction, trace it to the data or system gap preventing it, and sequence initiatives so each proof point funds the next.
Tie every initiative to a measurable outcome before technical work begins. ROI compounds across three dimensions: operational (reducing duplication and manual effort), strategic (enabling data-informed decisions on spend and revenue), and relational (improving patient or member engagement).
A connected operating model where every data and AI investment is structured around a commercial outcome, revenue, retention, or margin, before work begins. Each initiative builds on the last. Bridgenext designs every engagement this way.
Two consistent reasons: pursuing too many initiatives at once without a defined business outcome for each, and treating compliance as a final review rather than an architectural requirement, which leads to costly rework as regulations evolve.
With the single data or technology gap that most directly moves the outcome leadership cares about, DTC attribution for a pharma brand, AI-powered document intelligence for a health tech platform, or member engagement visibility for a life sciences association. Start there, prove value, and fund what follows.
